Title: The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients
Authors: Richir, M. C
Ellger, B
Teerlink, T
Siroen, M. P. C
Visser, M
Spreeuwenberg, M
Girbes, A. R. J
van der Hoven, B
Van den Berghe, Greet
Wilhelm, A. J
de Vries, Th. P. G. M
van Leeuwen, P. A. M # ×
Issue Date: Dec-2009
Publisher: Academic press ltd- elsevier science ltd
Series Title: Pharmacological research vol:60 issue:6 pages:519-524
Abstract: Asymmetric dimethylarginine (ADMA) plays a crucial role in the arginine-nitric oxide pathway. Critically ill patients have elevated levels of ADMA which proved to be a strong and independent risk factor for ICU mortality. The aim of this study was to investigate the effect of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist rosiglitazone on ADMA plasma levels in critically ill patients.
ISSN: 1043-6618
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Intensive Care Medicine
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science